ArticleCancers2024

Bortezomib in Combination with Physachenolide C Reduces the Tumorigenic Properties of KRAS

Thanigaivelan Kanagasabai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.